Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivax
Malaria vaccine development has largely focused on Plasmodium falciparum; however, a reawakening to the importance of Plasmodium vivax has spurred efforts to develop vaccines against this difficult to treat and at times severe form of relapsing malaria, which constitutes a significant proportion of...
Main Authors: | de Cassan, SC, Shakri, AR, Llewellyn, D, Elias, SC, Cho, JS, Goodman, AL, Jin, J, Douglas, AD, Suwanarusk, R, Nosten, FH, Rénia, L, Russell, B, Chitnis, CE, Draper, SJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2015
|
Similar Items
-
Preclinical assessment of viral vectored and protein vaccines targeting the Duffy-binding protein region II of Plasmodium vivax
by: Simone C de Cassan, et al.
Published: (2015-07-01) -
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
by: Payne, R, et al.
Published: (2017) -
Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein
by: Watson, QD, et al.
Published: (2023) -
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
by: Brian T Grimberg, et al.
Published: (2007-12-01) -
Naturally-acquired and vaccine-induced human monoclonal antibodies to plasmodium vivax Duffy binding protein inhibit invasion of Plasmodium knowlesi (pvdbpor) transgenic parasites
by: Watson, QD, et al.
Published: (2023)